New biomarker test could detect Alzheimer’s years before symptoms appear
The test can identify misfolded tau proteins years earlier than traditional imaging, enabling earlier Alzheimer’s diagnosis and improving treatment effectiveness.
Offering new hope for the early diagnosis and intervention of Alzheimer’s disease, researchers from the University of Pittsburgh (PA, USA) have created a novel biomarker test capable of detecting early misfolded tau protein—one of the hallmarks of Alzheimer’s—years before traditional imaging methods can identify its presence in the brain. The test has the potential to enhance clinicians’ ability to assess the complexities of Alzheimer’s pathology and enable early disease diagnostics.
